Lu Quan, Husein Mustafa, Jeyakumar Anita
Otolaryngology, Northeast Ohio Medical University, Rootstown, USA.
Otolaryngology, HEARS, LLC, Akron, USA.
Cureus. 2025 Jan 1;17(1):e76737. doi: 10.7759/cureus.76737. eCollection 2025 Jan.
Objective To examine the adverse events reported in the U.S. Food and Drug Administration's (U.S. FDA's) Manufacturer and User Facility Device Experience (MAUDE) database for prescription hearing aids (HA). Methods A retrospective study was performed from January 2014 to September 2024 using the U.S. FDA's MAUDE database. Medical device reports (MDRs) were identified using product codes (ESD, OSM, and QDD) and keywords ("Hearing Aid, Air-Conduction, Prescription; Hearing Aid, Air-Conduction with Wireless Technology, Prescription; and Self-fitting, Air-Conduction Hearing Aid, Prescription"). Exclusion criteria included reports unrelated to the usage of the device or those providing insufficient data. The incidence of adverse events was estimated using the Hearing Industries Association's market data over the last 10 years. Results A total of 586 medical device reports (MDRs) were identified, and 504 met the inclusion criteria. There were 4 (0.8%) MDRs identified in 2014, 7 (1.4%) in 2015, 7 (1.4%) in 2016, 11 (2.2%) in 2017, 7 (1.4%) in 2018, 27 (5.4%) in 2019, 50 (9.9%) in 2020, 24 (4.8%) in 2021, 119 (23.6%) in 2022, 174 (34.5%) in 2023, and 74 (14.7%) in 2024, up to the third quarter. Of the 504 MDRs, 829 total events were identified. The mean number of events per MDR was calculated as 1.9. Four hundred and ninety-four (59.6%) of the 829 events were related to device malfunction, with 180 (21.7%) attributed to charger-related issues and 137 (16.5%) to poor construction/device falling apart, resulting in foreign bodies in the ear for 96 (70.1%) of those 137 cases. A total of 303 (36.6%) events were related to adverse medical effects, 19 (2.3%) were related to customer service issues, and 11 (1.3%) were related to failure to provide hearing benefits. The incidence rate of adverse events over the last decade was calculated as 0.00114%. Conclusions There is a low reported incidence of adverse events associated with prescription hearing aids. Charger issues, possible poor construction and device failing apart, resulting in foreign bodies in the ear, and medical complications, were commonly reported as adverse events. The data can increase providers' awareness of common complaints, enhance targeted monitoring, and advise and manage expectations.
目的 研究美国食品药品监督管理局(U.S. FDA)的制造商和用户设施设备经验(MAUDE)数据库中报告的处方助听器(HA)不良事件。方法 利用U.S. FDA的MAUDE数据库进行了一项回顾性研究,时间跨度为2014年1月至2024年9月。使用产品代码(ESD、OSM和QDD)和关键词(“助听器,气导,处方;带无线技术的气导助听器,处方;以及自适配气导助听器,处方”)识别医疗器械报告(MDR)。排除标准包括与设备使用无关的报告或提供数据不足的报告。使用听力行业协会过去10年的市场数据估计不良事件的发生率。结果 共识别出586份医疗器械报告(MDR),其中504份符合纳入标准。2014年识别出4份(0.8%)MDR,2015年7份(1.4%),2016年7份(1.4%),2017年11份(2.2%),2018年7份(1.4%),2019年27份(5.4%),2020年50份(9.9%),2021年24份(4.8%),2022年119份(23.6%),2023年174份(34.5%),截至2024年第三季度为74份(14.7%)。在504份MDR中,共识别出829起事件。计算出每份MDR的平均事件数为1.9。829起事件中的494起(59.6%)与设备故障有关,其中180起(21.7%)归因于充电器相关问题,137起(16.5%)归因于结构不良/设备散架,在这137起案例中,有96起(70.1%)导致耳内异物。共有303起(36.6%)事件与不良医疗影响有关,19起(2.3%)与客户服务问题有关,11起(1.3%)与未能提供听力益处有关。过去十年不良事件的发生率计算为0.00114%。结论 报告的与处方助听器相关的不良事件发生率较低。充电器问题、可能的结构不良和设备散架导致耳内异物以及医疗并发症是常见报告的不良事件。这些数据可以提高提供者对常见投诉的认识,加强有针对性的监测,并为期望提供建议和管理。